Revlimid 10 Capsules — Lenalidomide 10 mg (21 Caps) Celgene
Revlimid 10 mg (Lenalidomide) is an original targeted immunomodulatory drug. It possesses a unique dual mechanism of action: it stops the growth of new blood vessels that feed tumors (anti-angiogenic) and directly stimulates the patient's immune system to attack and destroy malignant blood cells.
Manufacturer: Celgene (a Bristol Myers Squibb company). 🇹🇷 Note: This specific product is officially registered for the Turkish domestic market. It is a 100% authentic, original medication from the drug's developer, ensuring the highest global quality standards while offering a more accessible price.
Key Features:
- ✅ Dual Action: Starves cancer cells of blood supply while boosting immune response against them.
- ✅ Gold Standard: The foundational treatment for Multiple Myeloma worldwide.
- ✅ Convenient Cycle: A 21-capsule pack is perfectly designed to cover the active dosing phase of a standard 28-day treatment cycle.
Prescribed by a hematologist-oncologist for the treatment of adult patients with:
- 🔹 Multiple Myeloma (MM): As a first-line treatment (usually combined with dexamethasone), for relapsed disease, or as maintenance therapy following a stem cell transplant.
- 🔹 Myelodysplastic Syndromes (MDS): For transfusion-dependent anemia caused by specific genetic abnormalities (deletion 5q).
- 🔹 Lymphomas: Previously treated Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL).
Sales Unit: Carton containing 21 capsules. Strength: 10 mg per capsule.
⚠️ APPLICATION INSTRUCTIONS:
- Dosage Schedule (Standard for MM): Take 1 capsule (10 mg) once daily for 21 consecutive days, followed by a 7-day rest period (forming a 28-day cycle). The exact dose is determined by the doctor.
- Administration: Take at about the same time each day, with or without food. Swallow with a glass of water.
- ✋ Crucial Warning: Capsules must be swallowed whole! Never open, break, or chew them. The powder inside is highly hazardous if it touches the skin or is inhaled.
- ⛔ Pregnancy (STRICTLY CONTRAINDICATED): Lenalidomide is highly teratogenic (causes severe, life-threatening birth defects). All patients (male and female) must strictly adhere to a Pregnancy Prevention Program and use highly effective contraception.
- Breastfeeding.
- Severe renal impairment (requires dose adjustment).
- Children and adolescents under 18 years of age.
Treatment requires frequent blood tests and medical supervision. Potential side effects include:
- 🩸 Blood Counts: Neutropenia (low white blood cells, risk of infection) and thrombocytopenia (low platelets, risk of bleeding) are very common.
- ⚠️ Blood Clots: Significantly increased risk of deep vein thrombosis (DVT) and pulmonary embolism (doctors almost always prescribe blood thinners alongside Revlimid).
- 💤 General: Extreme fatigue, weakness (asthenia).
- 🤢 Gastrointestinal: Diarrhea, constipation, nausea.
- 🔴 Skin: Rash, itching, dry skin.
What Customers Say
No reviews yet
Your review can be the first!